CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Long-term management of resistant, fistulazing Crohn's disease by ongoing 4-weekly infliximab therapy (a case report)
DOI 10.1055/s-2005-869761
Bibliografische Angaben
Nachweis in CareLit
Autor:innenR Schwab, P Lakatos, E Schäfer, J Weltner, A Sáfrány, Á Pap, J Papp
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Management of fistulizing Crohn's disease has been revolutionized by anti-TNF biologics. Scheduled ongoing anti-TNF therapy for maintenance, with a recommended frequency of 8 weeks has been established by the ACCENT-I trial and subsequent analyses (eg. Gastroenterology,126:402–413). However, almost two third of patients remain symptomatic. Our Patient: is a 20 year-old male subject with a 3 years' histor…
Zitieren
Zitierempfehlung
R Schwab, P Lakatos, E Schäfer, J Weltner, A Sáfrány, Á Pap, J Papp (2005) Long-term management of resistant, fistulazing Crohn's disease by ongoing 4-weekly infliximab therapy (a case report). Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-2005-869761
Mit CareLit weiterarbeiten